Scientific publications

Depression and Anxiety, 2026

Plasma Proteomic Landscape of Multidimensional Sleep Health and Its Association With Depression Risk Under Genetic Susceptibility

Chen F., Hong Y., Zhu Y. et al.

International Journal of Colorectal Disease, 2026

Preoperative serum interleukin-6 and severe postoperative complications after colorectal cancer resection

Peroja P., Rintala J., Tuomisto A. et al.

Psychiatry Research, 2026

Investigating the relationship between inflammatory cytokines and PTSD: A comparative analysis

Zhou Y., Peng S., Luo H. et al.

Journal of Affective Disorders, 2026

Cardiorespiratory fitness and risk of depression and anxiety: A prospective cohort study with proteomic profiling in the UK Biobank

Liu Y., Li Y., Liu X. et al.

Arteriosclerosis, Thrombosis, and Vascular Biology, 2026

Short-Term Dietary Exposures and Thrombin Generation in Tanzanian Men: Exploratory Coagulation-Focused Analysis of a Randomized Dietary-Switch Trial

Kisali E., Roest M., Pecht T. et al.

Leukemia, 2026

Generation of a novel knock-in mouse line expressing oncogenic Kit D814V in the hematopoietic stem cell compartment as a preclinical model for systemic mastocytosis

Stivala S., Makeeva A., Almeida Fonseca T. et al.

Journal of Translational Autoimmunity, 2026

Integrating multiple omics approaches to identify AIF1 as a protective factor in IgA nephropathy

Liu X., Hu Y., Zhang W. et al.

iScience, 2026

Plasma proteomic analysis identified potential therapeutic targets for pulmonary arterial hypertension

Hu S., Xie Y., Tan J. et al.

American Heart Journal Plus: Cardiology Research and Practice, 2026

Proteomic markers associated with blood pressure, hypertension, and treatment-resistant hypertension

Dieden A., Melander O., Pareek M. et al.

Multiple Sclerosis Journal – Experimental, Translational and Clinical, 2026

Impact of treatment mechanism on octave MSDA pathway scores in patients receiving ocrelizumab or natalizumab

Heidari H., Maghbooli Z., Zabeti A.

Bioorganic Chemistry, 2026

A natural product-derived degrader (COT-01): cortisone-based CRBN recruitment for cyclin D2 degradation in multiple myeloma

Lee S., Kim S., Lee K. et al.

npj Digital Medicine, 2026

A generalizable biopsychosocial risk score for stratifying disease vulnerability in healthy populations

Chen J., Chu C., Garcia-Argibay M. et al.

Genomics, Proteomics & Bioinformatics, 2026

Distinct Genetic Determinants of Plasma Inflammatory Proteins in Tanzanian and Dutch Populations

Amour C., Boahen C., Temba G. et al.

Molecular Medicine, 2026

CD248 expression in human adipose tissue is upregulated in obesity and following glucocorticoid exposure: a mediator of insulin resistance and adipose dysfunction?

Laterveer R., Lundqvist M., Conway E. et al.

Nature Communications, 2026

Clonal haematopoiesis subtypes confer dose-dependent risk of serious bacterial infection

Fewings E., Yu Z., Gutierrez J. et al.

Aging Cell, 2026

Chronic Senolytic Treatment and/or Aerobic Exercise Reduce Senescence and Improve Myocardial Function During Aging in the Heart

Bevington R., Johnson A., Hockey B. et al.

Genome Medicine, 2026

Proteomic risk scores facilitate early prediction of cardiometabolic diseases in pre-clinical obesity

Liu Y., Dong D., Cheskin L. et al.

Hepatology International, 2026

Plasma proteomic signatures of biological aging and metabolic dysfunction-associated steatotic liver disease risk: a prospective cohort study

Cao T., Wu L., Yang X. et al.

JHEP Reports, 2026

Hyperinflammatory reprogramming marks the transition from MASH to HCC

Tan S., Israeli E., Wee J. et al.

Experimental Gerontology, 2026

Perceived psychosocial stressors and inflammatory biomarkers among urban-dwelling older Black adults

Adeola H., Yaskolka Meir A., Tasaki S. et al.